Mantini Tablets 20mg (Memantine Hydrochloride)
Memantine Hydrochloride 20mg
Tablet · Prescription medication
Withers Pharmaceutical Co., Ltd.
MFDS item code 202500919 · Approved 2025.04.16
Treatment of moderate to severe Alzheimer's disease
This medication is used for the treatment of moderate to severe Alzheimer's disease.
This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. Adult dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Day 1~7): Administer 5mg once daily for 7 days. Week 2 (Day 8~14): Administer 10mg once daily for 7 days. Week 3 (Day 15~21): Administer 15mg once daily for 7 days. From Week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg once daily. No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This medication should not be used in patients who are allergic to any component of this medication. It is also safest to avoid administration in patients with severely impaired liver function or severely impaired kidney function. Patients with epilepsy or a history of seizures, and those with a predisposition to epilepsy should use this medication with caution. When taken with certain medications, central nervous system side effects may be increased, so it should not be taken with drugs such as amantadine, ketamine, and dextromethorphan. If urine acidity changes, it may affect the excretion of this medication, so close observation is required. There is insufficient data on the use of this medication in patients with recent myocardial infarction, heart failure, or uncontrolled hypertension, so caution is needed. Common side effects when taking this medication may include dizziness, headache, constipation, drowsiness, and hypertension; if symptoms are severe, consult a doctor. Since there may be interactions with other medications, it is essential to inform your healthcare provider about any medications you are currently taking, especially when used with antipsychotic drugs, muscle relaxants, and anticoagulants. Pregnant women should discuss the use of this medication with their doctor, as its safety has not been established. While breastfeeding, there is a possibility that this medication may pass into breast milk, so nursing should be temporarily discontinued during treatment. This medication has not been established for safety and efficacy in children or adolescents under the age of 18; therefore, it is advisable not to use it in this age group. In cases of overdose, severe symptoms such as coma, hallucinations, seizures, and vomiting may occur, and if overdose is suspected, immediate medical attention should be sought. There is no specific antidote, and treatment will be symptomatic. This medication is administered to patients with severe Alzheimer's disease, so caution is needed as it may impair concentration while driving or operating machinery. Finally, this medication should be stored out of reach of children, and it is recommended not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and ensure safe use.
Pink oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Memantine Hydrochloride 20mg
Tablet · Prescription medication
Withers Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.